Kim Merritt

Paralegal Specialist
Full contact info

Passions

Traveling

Entertaining

Spending time with family and friends

Experience

Ascendis Pharma – $575 Million Convertible Senior Notes Offering

April 6, 2022

Cooley advised the initial purchasers on Ascendis Pharma’s offering of $575 million aggregate principal amount of 2.25% Convertible Senior Notes due 2028 and the concurrent repurchase of 1,000,000 of its American Depositary Shares. J.P. Morgan, Evercore ISI, Wells Fargo Securities, Morgan Stanley and Credit Suisse acted as joint book-running managers for the offering. SVB Leerink acted as lead co-manager for the offering. Cantor, Canaccord Genuity and Berenberg acted as co-managers for the offering.  Ascendis Pharma is a biopharmaceutical company creating new product candidates that address unmet medical needs. Partners Denny Won, Mischi a Marcha, Jason Savich, Charlie Kim and Div Gupta led the Cooley team advising the initial purchasers.

Related contacts

Denny Won
Partner, San Francisco
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Charlie Kim
Partner, San Diego
Div Gupta
Partner, New York
Madison (JJ) Meng
Associate, San Francisco
Mike Lam
Associate, Los Angeles Santa Monica
Timothy Nguyen
Special Counsel, San Francisco
Matthew S. Scarano
Associate, San Diego
Kim Merritt
Paralegal Specialist, San Francisco

Related Practices & Industries

Sweetgreen – $418.6 Million IPO

December 6, 2021

Cooley advised restaurant chain sweetgreen on its $418.6 million initial public offering of 14,950,000 shares of Class A common stock, which now trade on the New York Stock Exchange under the symbol SG. Partners Nick Hobson, David Peinsipp, Siana Lowrey and Charlie Kim led the Cooley team advising sweetgreen.

Read more

Related contacts

Nick Hobson
Partner in Charge, Los Angeles – Santa Monica, Los Angeles Santa Monica
David Peinsipp
Partner, San Francisco
Siana Lowrey
Partner, San Francisco
Charlie Kim
Partner, San Diego
Julia Boesch
Partner, San Francisco
Mark Cikowski
Associate, Los Angeles Santa Monica
Marjorie Roesser
Associate, San Francisco
Eric Steiner
Paralegal Specialist, San Francisco
Amy Saldamando
Paralegal Specialist, Los Angeles Santa Monica
Kim Merritt
Paralegal Specialist, San Francisco
Barbara Mirza
Partner, Los Angeles Santa Monica
Austin Holt
Partner, Los Angeles Santa Monica
David Navetta
Partner, Colorado
Christian Lee
Associate, San Francisco
Maricel Mojares-Moore
Special Counsel, San Francisco
Matt Kong
Associate, San Francisco
Ross Eberly
Partner, Los Angeles Santa Monica
Eileen Leman
Associate, Los Angeles Downtown
Karen Tsai
Special Counsel, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stephanie Gentile
Partner, New York
John Paul Oleksiuk
Partner, New York
Colette Ghazarian
Associate, Los Angeles Downtown
Sharon Connaughton
Special Counsel, Washington, DC
Patrick Gibbs
Partner, Palo Alto
Francis Wheeler
Partner, Colorado
Michael Suyat
Senior Paralegal, San Francisco

Related Practices & Industries

Erasca – $345 Million IPO

July 16, 2021

Cooley advised the underwriters on Erasca’s $345 million initial public offering of 21,562,500 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. J.P. Morgan, Morgan Stanley, BofA Securities, Evercore ISI and Guggenheim Securities acted as joint book-running managers for the offering. Erasca, whose securities now trade on the Nasdaq Global Select Market under the symbol ERAS, is a clinical-stage precision oncology company focused on discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Partners Charlie Kim, Sean Clayton and Kristin VanderPas led the Cooley team.

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
David D. Kim
Associate, San Francisco
Julia Gage
Associate, San Francisco
Kim Merritt
Paralegal Specialist, San Francisco
Madhuri Roy
Partner, Palo Alto

Related Practices & Industries

Olive Hits $4 Billion Valuation With Latest Funding Round

July 9, 2021

Cooley advised digital health automation company Olive on its $400 million funding round, which brings its valuation to $4 billion. Lawyers Peter Werner and Melissa Boyd led the Cooley team advising Olive.

Read more

Related contacts

Peter H. Werner
Partner in Charge – San Francisco, San Francisco
Melissa H. Boyd
Associate, San Francisco
Jodie Bourdet
Partner, San Francisco
Eric M. Walder
Associate, San Francisco
Kim Merritt
Paralegal Specialist, San Francisco
Blake Martell
Partner, San Francisco

Related Practices & Industries

NVIDIA – $5 Billion Senior Unsecured Notes Offering

June 30, 2021

Cooley advised NVIDIA on its registered debt offering of $5 billion aggregate principal amount of investment grade senior unsecured notes. The offering consisted of $1.25 billion aggregate principal amount of 0.309% notes due 2023; $1.25 billion aggregate principal amount of 0.584% notes due 2024; $1.25 billion aggregate principal amount of 1.550% notes due 2028; and $1.25 billion aggregate principal amount of 2.000% notes due 2031. Partners Michael Tollini, Mischi a Marca, Jason Savich, Eric Jensen and John McKenna led the Cooley team advising NVIDIA.

Read more

Related contacts

Michael Tollini
Partner, Washington, DC
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Eric Jensen
Vice Chair, Palo Alto
John McKenna
Partner, Palo Alto
Natalie Karam
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Karen Gustavson
Associate, Seattle
Annelise Bertrand
Associate, Palo Alto
Kim Merritt
Paralegal Specialist, San Francisco
Timothy Nguyen
Special Counsel, San Francisco
Savannah Harms
Associate, New York
Eileen Marshall
Partner, Washington, DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Patrick Gibbs
Partner, Palo Alto
Francis Wheeler
Partner, Colorado

Related Practices & Industries

View more

Memberships & affiliations

San Francisco Paralegal Association